Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Lei Yun Shang Pharmaceutical is a specialized manufacturing and research subsidiary of the Lei Yun Shang Pharmaceutical Group, one of China's most historic Traditional Chinese Medicine (TCM) brands with a legacy dating back to 1734. Located in Bozhou, the world's largest hub for TCM trade, the company operates modern, GMP-certified facilities dedicated to the production of diverse herbal formulations including tablets, capsules, and granules. Its product portfolio leverages centuries of traditional herbal wisdom to address prevalent health conditions such as respiratory infections, cardiovascular diseases, and digestive ailments. By integrating ancient recipes with contemporary pharmaceutical technology and rigorous quality control, the company ensures the standardization and efficacy of its products. Anhui Lei Yun Shang plays a critical role in the group's supply chain and its broader mission to modernize and globalize Traditional Chinese Medicine. The company is recognized as a high-tech enterprise within Anhui Province, contributing significantly to the regional life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Lei Yun Shang Pharmaceutical.